Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (351-360 of 527) with videos related to

Pageof 53
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
[<sup>177</sup>Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II TrialNathalie L Albert, Emeline Tabouret, Emilie Le Rhun, et al.
Neuro-Oncology|November 19, 2024
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessmentsKatharina J Müller, Robert Forbrig, Jonas Reis, et al.
Neuroimage|February 18, 2019
High-resolution metabolic mapping of gliomas via patch-based super-resolution magnetic resonance spectroscopic imaging at 7TGilbert Hangel, Saurabh Jain, Elisabeth Springer, et al.
European Radiology|January 5, 2017
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastasesJulia Furtner, Anna S Berghoff, Omar M Albtoush, et al.
Frontiers in Cardiovascular Medicine|November 8, 2021
Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or CancerHenrike Arfsten, Anna Cho, Suriya Prausmüller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2025
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningiomaMaximilian J Mair, Sabrina Hartenbach, Erwin Tomasich, et al.
Journal of Neurosurgery|August 18, 2018
Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningiomaMichael D Jenkinson, Damien C Weber, Brian J Haylock, et al.
Radiology. Imaging Cancer|September 12, 2025
High-Resolution Mapping of Tumor and Peritumoral Glutamate and Glutamine in Gliomas Using 7-T MRSIGilbert Hangel, Philipp Lazen, Cornelius Cadrien, et al.
Cancers|November 4, 2020
p53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death InductionCarina Dinhof, Christine Pirker, Philipp Kroiss, et al.
Annals of Surgical Oncology|April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal AdenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Pageof 53

Showing results (351-360 of 527) with videos related to

Sort By:
Pageof 53
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
[<sup>177</sup>Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II TrialNathalie L Albert, Emeline Tabouret, Emilie Le Rhun, et al.
Neuro-Oncology|November 19, 2024
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessmentsKatharina J Müller, Robert Forbrig, Jonas Reis, et al.
Neuroimage|February 18, 2019
High-resolution metabolic mapping of gliomas via patch-based super-resolution magnetic resonance spectroscopic imaging at 7TGilbert Hangel, Saurabh Jain, Elisabeth Springer, et al.
European Radiology|January 5, 2017
Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastasesJulia Furtner, Anna S Berghoff, Omar M Albtoush, et al.
Frontiers in Cardiovascular Medicine|November 8, 2021
Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or CancerHenrike Arfsten, Anna Cho, Suriya Prausmüller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2025
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningiomaMaximilian J Mair, Sabrina Hartenbach, Erwin Tomasich, et al.
Journal of Neurosurgery|August 18, 2018
Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningiomaMichael D Jenkinson, Damien C Weber, Brian J Haylock, et al.
Radiology. Imaging Cancer|September 12, 2025
High-Resolution Mapping of Tumor and Peritumoral Glutamate and Glutamine in Gliomas Using 7-T MRSIGilbert Hangel, Philipp Lazen, Cornelius Cadrien, et al.
Cancers|November 4, 2020
p53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death InductionCarina Dinhof, Christine Pirker, Philipp Kroiss, et al.
Annals of Surgical Oncology|April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal AdenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Pageof 53